EUCTR2009-014582-51-DE进行中（未招募）不适用
Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levels
Faculty of Medicine, Technische Universität München0 个研究点开始时间: 2009年10月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Diagnosis of severe atopic dermatitis (potentially associated with bronchial asthma and/or allergic rhinitis)
- •- Total serum IgE level > 700 IU/ml
- •- SCORAD > 50 within the last 12 months
- •- resistance or relapse to/after at least 2 systemic treatment modalities for atopic dermatitis
- •- No parallel systemic therapies during the omalizumab treatment period
- •- Adults > 18 years of age
- •- Both parents of Caucasian heritage
- •- Residence in the greater Munich area
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- other chronic dieseases such as diabetes, hematological disorders etc.
- •- autoimmune diseases
- •- Cardiopulmonary/cardiovascular diseases
- •- Allergies against any of the used material or IMP
- •- Systemic infections (such as HIV-infection etc)
- •- Systemic medication other than contraceptives
- •- Pregnancy
- •- Breast feeding (nursing)
- •- Parasitic infections
- •- Planed or recent travel to regions endemic for parasitic infections
研究者
相似试验
尚未招募
不适用
Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancermetastatic breast cancerJPRN-UMIN000035869The University of Tokushima Graduate School, Depertment of Thoracic, Endocrine surgery and Oncology, Institute of Health Bioscience30
招募中
不适用
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
未知
3 期
Clinical investigation for combination therapy of KAD-1229 and Pioglitazone.Type 2 diabetesJPRN-jRCT2080220136KISSEI PHARMACEUTICAL CO.,LTD.
招募中
不适用
Clinical investigation of combination therapy with a1 blocker and vibegron for treating overactive bladder in patients with benign prostatic hyperplasiaoveractive bladderJPRN-UMIN000039150Koto Hospital, Dept. of Urology50
已完成
2 期
Phase II clinical trial of combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary diseaseCOPDJPRN-UMIN000015222ational Hospital Organization Toneyama National Hospital10